Ann: US patent for next generation neurodegenerative diseases, page-58

i could be a bit off here , but seems like there will be 2bn SOI post tranche 2. even more when you factor dully diluted.

however, at 4.4c , thats 88m MC with 40m cash for a lot of study and newsflow.

given the potential market size of a successful outcome and the fact no more raisings would be needed, this represents great investment value.

ST headwinds of the huge number of shares hitting the register from last CR should cap the SP and allow buyers to accumulate, but my guess is some big heavyweights will take position's.